Literature DB >> 35597865

The function of LncRNA-ATB in cancer.

Amir Anbiyaiee1, Mohammad Ramazii2, Siamak Soltani Bajestani3, Seyed Mohammadmahdi Meybodi4, Mona Keivan5, Seyed Esmaeil Khoshnam6, Maryam Farzaneh7.   

Abstract

Cancer as a progressive and complex disease is caused by early chromosomal changes and stimulated cellular transformation. Previous studies reported that long non-coding RNAs (lncRNAs) play pivotal roles in the initiation, maintenance, and progression of cancer cells. LncRNA activated by TGF-β (ATB) has been shown to be dysregulated in different types of cancer. Aberrant expression of lncRNA-ATB plays an important role in the progression of diverse malignancies. High expression of LncRNA-ATB is associated with cancer cell growth, proliferation, metastasis, and EMT. LncRNA-ATB by targeting various signaling pathways and microRNAs (miRNAs) can trigger cancer pathogenesis. Therefore, lncRNA-ATB can be a novel target for cancer prediction and diagnosis. In this review, we will focus on the function of lncRNA-ATB in various types of human cancers.
© 2022. The Author(s), under exclusive licence to Federación de Sociedades Españolas de Oncología (FESEO).

Entities:  

Keywords:  Cancer; LncRNA-ATB; Long non-coding RNAs; Signaling pathways; miRNAs

Year:  2022        PMID: 35597865     DOI: 10.1007/s12094-022-02848-1

Source DB:  PubMed          Journal:  Clin Transl Oncol        ISSN: 1699-048X            Impact factor:   3.405


  76 in total

Review 1.  Cytoplasmic functions of long noncoding RNAs.

Authors:  Ji Heon Noh; Kyoung Mi Kim; Waverly G McClusky; Kotb Abdelmohsen; Myriam Gorospe
Journal:  Wiley Interdiscip Rev RNA       Date:  2018-03-08       Impact factor: 9.957

Review 2.  Interactions between short and long noncoding RNAs.

Authors:  Igor Ulitsky
Journal:  FEBS Lett       Date:  2018-05-23       Impact factor: 4.124

Review 3.  Emerging roles of lncRNA in cancer and therapeutic opportunities.

Authors:  Ming-Chun Jiang; Jiao-Jiao Ni; Wen-Yu Cui; Bo-Ya Wang; Wei Zhuo
Journal:  Am J Cancer Res       Date:  2019-07-01       Impact factor: 6.166

4.  Quantifying gene selection in cancer through protein functional alteration bias.

Authors:  Nadav Brandes; Nathan Linial; Michal Linial
Journal:  Nucleic Acids Res       Date:  2019-07-26       Impact factor: 16.971

Review 5.  Targeting transcription cycles in cancer.

Authors:  Stephin J Vervoort; Jennifer R Devlin; Nicholas Kwiatkowski; Mingxing Teng; Nathanael S Gray; Ricky W Johnstone
Journal:  Nat Rev Cancer       Date:  2021-10-21       Impact factor: 60.716

6.  HiChIRP reveals RNA-associated chromosome conformation.

Authors:  Maxwell R Mumbach; Jeffrey M Granja; William J Greenleaf; Howard Y Chang; Ryan A Flynn; Caitlin M Roake; Ansuman T Satpathy; Adam J Rubin; Yanyan Qi; Zhaozhao Jiang; Shadi Shams; Bryan H Louie; Jimmy K Guo; David G Gennert; M Ryan Corces; Paul A Khavari; Maninjay K Atianand; Steven E Artandi; Katherine A Fitzgerald
Journal:  Nat Methods       Date:  2019-05-27       Impact factor: 28.547

Review 7.  Gene regulation by long non-coding RNAs and its biological functions.

Authors:  Luisa Statello; Chun-Jie Guo; Ling-Ling Chen; Maite Huarte
Journal:  Nat Rev Mol Cell Biol       Date:  2020-12-22       Impact factor: 94.444

Review 8.  Cancer as a Metabolic Disorder.

Authors:  Jones Gyamfi; Jinyoung Kim; Junjeong Choi
Journal:  Int J Mol Sci       Date:  2022-01-21       Impact factor: 5.923

Review 9.  Long noncoding RNAs and the genetics of cancer.

Authors:  S W Cheetham; F Gruhl; J S Mattick; M E Dinger
Journal:  Br J Cancer       Date:  2013-05-09       Impact factor: 7.640

View more
  2 in total

Review 1.  LncRNA MALAT1-related signaling pathways in osteosarcoma.

Authors:  Maryam Farzaneh; Sajad Najafi; Omid Anbiyaee; Shirin Azizidoost; Seyed Esmaeil Khoshnam
Journal:  Clin Transl Oncol       Date:  2022-07-06       Impact factor: 3.340

Review 2.  Functional roles of long noncoding RNA MALAT1 in gynecologic cancers.

Authors:  Maryam Farzaneh; Sajad Najafi; Mahrokh Abouali Gale Dari; Mohadeseh Sheykhi-Sabzehpoush; Diyan Dayer; Maryam Cheraghzadeh; Shirin Azizidoost
Journal:  Clin Transl Oncol       Date:  2022-08-30       Impact factor: 3.340

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.